dexamethasone 21-phosphate has been researched along with Benign Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, MR; Jiles, C; Seibel, NL | 1 |
Futatsugi, K; Kobayashi, H; Koizumi, W; Komatsu, H; Minato, K; Nakarai, I; Nukariya, N; Taira, O; Uchiyama, T; Yamaguchi, T | 1 |
Azuara, ML; Barcia, E; Negro, S; Reyes, R; Sánchez, Y | 1 |
1 trial(s) available for dexamethasone 21-phosphate and Benign Neoplasms
Article | Year |
---|---|
[A comparative study of the effect of granisetron and a combination of granisetron plus steroids on cancer chemotherapy induced emesis].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasms; Vomiting | 1995 |
2 other study(ies) available for dexamethasone 21-phosphate and Benign Neoplasms
Article | Year |
---|---|
Aprepitant use in children, adolescents, and young adults for the control of chemotherapy-induced nausea and vomiting (CINV).
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Child; Child, Preschool; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Morpholines; Nausea; Neoplasms; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Vomiting | 2010 |
Physical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Butylscopolammonium Bromide; Dexamethasone; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Haloperidol; Humans; Infusion Pumps; Male; Metoclopramide; Midazolam; Middle Aged; Morphine; Neoplasms; Palliative Care; Spain; Tramadol; Treatment Outcome | 2002 |